
|Articles|October 1, 1997
- Oncology NEWS International Vol 6 No 10
- Volume 6
- Issue 10
A Picture of Prostate Cancer in Europe
HAMBURG-The Federation of European Cancer Societies released information on prostate cancer in Europe at its biennial European Cancer Conference (ECCO 9).
Advertisement
HAMBURGThe Federation of European Cancer Societies released information on prostate cancer in Europe at its biennial European Cancer Conference (ECCO 9).
- In Europe, one man in 11 is diagnosed with prostate cancer, which accounts for 13% of all new cancer diagnoses and almost 9% of cancer deaths.
- The death rate tends to be highest in northern European countries and lowest in southern and eastern Europe.
- Death rates from prostate cancer have risen dramatically in recent years, probably because of the increasing number of elderly men in the population. In England and Wales, for example, there were 4,313 deaths attributed to prostate cancer in 1974, compared with 8,735 in 1992, a 103% increase in only 17 years.
Articles in this issue
about 28 years ago
Toremifene, Tamoxifen Equivalent in Advanced Breast Cancerabout 28 years ago
Fluorescence ‘LIFE’ Images Spot Occult Lung Cancer Lesionsabout 28 years ago
The Issue That Won’t Go Away: Screening Mammographyabout 28 years ago
News in Brief...about 28 years ago
Concurrent Better Than Sequential Chemo-RT in NSCLCabout 28 years ago
Consumer Version of Merck & Co’s Famous Manual Is Availableabout 28 years ago
A Talk With Dr. Richard Klausner, Head of the NCIabout 28 years ago
Age Is a Factor in Survival of SqCC of the Head and Neckabout 28 years ago
Symptom-Based Staging of Head & Neck CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
An Oncodermatologist’s Perspective on Dermatological Toxicities in Breast Cancer
3
Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer
4
How Can Lower-Income Countries Maintain Representation in Clinical Trials?
5


















































































